SQZ Biotechnologies (SQZ) Competitors $0.03 0.00 (0.00%) As of 08/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock SQZ vs. CISS, OP, GVH, USDP, AIRTP, BLDEW, RA, HSHP, IMPPP, and PXSAWShould you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include C3is (CISS), OceanPal (OP), Globavend (GVH), USD Partners (USDP), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), Himalaya Shipping (HSHP), Imperial Petroleum (IMPPP), and Pyxis Tankers (PXSAW). These companies are all part of the "transportation" industry. SQZ Biotechnologies vs. Its Competitors C3is OceanPal Globavend USD Partners Air T Blade Air Mobility Brookfield Real Assets Income Fund Himalaya Shipping Imperial Petroleum Pyxis Tankers C3is (NASDAQ:CISS) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership. Which has better earnings and valuation, CISS or SQZ? C3is has higher revenue and earnings than SQZ Biotechnologies. C3is is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioC3is$42.30M0.05-$2.75M-$51.85-0.06SQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01 Does the media prefer CISS or SQZ? In the previous week, C3is' average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score. Company Overall Sentiment C3is Neutral SQZ Biotechnologies Neutral Do institutionals & insiders hold more shares of CISS or SQZ? 10.5% of C3is shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is CISS or SQZ more profitable? C3is has a net margin of 3.62% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 7.94% beat SQZ Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets C3is3.62% 7.94% 5.19% SQZ Biotechnologies -369.96%-119.83%-59.90% Which has more volatility & risk, CISS or SQZ? C3is has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. SummaryC3is beats SQZ Biotechnologies on 6 of the 11 factors compared between the two stocks. Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SQZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SQZ vs. The Competition Export to ExcelMetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$826K$279.92M$5.73B$20.87BDividend YieldN/AN/A4.53%3.60%P/E Ratio-0.01N/A30.4628.31Price / Sales0.05538.67392.5752.52Price / CashN/A22.4437.0323.77Price / Book0.0110.148.955.19Net Income-$79.46M-$115.81M$3.26B$992.10M7 Day PerformanceN/A-1.96%1.06%-0.30%1 Month PerformanceN/A-5.46%4.31%1.20%1 Year PerformanceN/A-11.41%28.39%10.50% SQZ Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SQZSQZ BiotechnologiesN/A$0.03flatN/A-72.0%$826K$18.16M-0.011,620CISSC3is0.0769 of 5 stars$3.30flatN/A-84.3%$2.33M$42.30M-0.06N/APositive NewsUpcoming EarningsOPOceanPalN/A$0.09-5.7%N/A-94.1%$760K$25.70M-0.0460News CoveragePositive NewsStock SplitGap DownGVHGlobavend0.9657 of 5 stars$4.80-2.6%$80.00+1,566.7%-95.8%$359K$16.54M0.007USDPUSD PartnersN/A$0.01flatN/A-77.3%$199K$72.32M-0.0190AIRTPAir TN/A$18.45-4.2%N/A+4.8%$0.00$296.31M0.00500Short Interest ↑Gap DownBLDEWBlade Air MobilityN/A$0.15-7.6%N/A-6.3%$0.00$254.34M0.00130Gap DownRABrookfield Real Assets Income FundN/A$13.19+0.4%N/A+1.2%$0.00$67.52M-119.86N/AShort Interest ↓HSHPHimalaya Shipping0.0669 of 5 stars$7.49+1.6%N/A+1.0%$0.00$123.58M53.472Ex-DividendIMPPPImperial PetroleumN/A$25.49-1.7%N/A+4.5%$0.00$138.37M0.00N/APositive NewsPXSAWPyxis TankersN/A$0.01-8.8%N/A-99.2%$0.00$44.58M0.004 Related Companies and Tools Related Companies CISS Competitors OP Competitors GVH Competitors USDP Competitors AIRTP Competitors BLDEW Competitors RA Competitors HSHP Competitors IMPPP Competitors PXSAW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SQZ) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access